Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NIH R01 38325-19 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study examines whether an antioxidant taken orally will improve glucose tolerance and insulin secretion in type 2 diabetic subjects.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Placebo | Placebo Comparator |
| |
| antioxidant drug | Active Comparator | n-acetylcysteine |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Placebo | Drug | one capsule BID |
| |
| n-aceylcysteine |
| Measure | Description | Time Frame |
|---|---|---|
| Blood glucose | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| HbA1c levels | 3 months |
Not provided
Inclusion Criteria: Subjects with a known diagnosis of type 2 diabetes -
Exclusion Criteria: None, except known intolerance to n-acetylcysteine
-
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pacific Northwest Research Institute | Seattle | Washington | 98122 | United States |
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
450 mgm BID |
|
| D004700 | Endocrine System Diseases |